As of 2025-04-24, the Intrinsic Value of Castle Biosciences Inc (CSTL) is 10.47 USD. This CSTL valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 21.98 USD, the upside of Castle Biosciences Inc is -52.40%.
The range of the Intrinsic Value is 7.59 - 28.80 USD
Based on its market price of 21.98 USD and our intrinsic valuation, Castle Biosciences Inc (CSTL) is overvalued by 52.40%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 7.59 - 28.80 | 10.47 | -52.4% |
| DCF (Growth 10y) | 26.94 - 157.35 | 44.61 | 103.0% |
| DCF (EBITDA 5y) | 21.42 - 32.63 | 23.39 | 6.4% |
| DCF (EBITDA 10y) | 33.63 - 55.47 | 38.45 | 74.9% |
| Fair Value | 3.16 - 3.16 | 3.16 | -85.61% |
| P/E | 14.40 - 21.55 | 19.54 | -11.1% |
| EV/EBITDA | 12.51 - 16.67 | 12.88 | -41.4% |
| EPV | (14.15) - (21.45) | (17.80) | -181.0% |
| DDM - Stable | 8.44 - 68.22 | 38.33 | 74.4% |
| DDM - Multi | 30.10 - 192.98 | 52.46 | 138.7% |
| Market Cap (mil) | 633.90 |
| Beta | 0.60 |
| Outstanding shares (mil) | 28.84 |
| Enterprise Value (mil) | 524.63 |
| Market risk premium | 4.60% |
| Cost of Equity | 7.04% |
| Cost of Debt | 4.48% |
| WACC | 6.99% |